Metabolic Profiling of Distinct TP53-Mutant Esophageal Adenocarcinoma Models Reveals Different Bioenergetic Dependencies
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26146869 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Erica Cataldi-Stagetti und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical and Surgical Sciences (DIMEC), University of Bologna, 40126 Bologna, Italy. Hauptthemen laut MEDLINE: Esophageal Neoplasms, Tumor Suppressor Protein p53, Adenocarcinoma, Mutation. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of University.
Abstract (Originalsprache)
Esophageal adenocarcinoma (EAC) is a highly aggressive malignancy with rising incidence and poor prognosis. TP53, previously identified as the most frequently mutated gene in EAC in our studies, plays a central role in tumor suppression and regulation. However, the metabolic consequences of TP53 mutations in EAC remain largely uncharacterized. We metabolically profiled three TP53-mutant EAC cell models (OE33, OE19, and FLO1) representing progressive stages of tumor differentiation and harboring distinct TP53 alterations. Our analyses revealed different metabolic phenotypes associated with TP53 status. OE33 cells predominantly use glycolytic metabolism but display limited adaptability to environmental changes, possibly due to a higher differentiation state. FLO1 cells exhibit a strong glycolytic dependence, elevated lactate production, and robust proliferation under acidic conditions, consistent with an aggressive and metastatic phenotype. OE19 cells preferentially utilize oxidative phosphorylation, demonstrated by resilience to glucose and glutamine deprivation, and ROS accumulation. These findings highlight the metabolic plasticity of EAC and suggest that TP53 mutation type might influence bioenergetic dependencies. Targeting these metabolic vulnerabilities may offer novel therapeutic avenues for personalized treatment in EAC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical and Surgical Sciences (DIMEC), University of Bologna, 40126 Bologna, Italy.
- Department of Pharmacy and Biotechnology, University of Bologna, 40126 Bologna, Italy.
- Piattaforma Medicina e Biologia Molecolare, IRCCS Azienda Ospedaliero, Universitaria di Bologna, 40126 Bologna, Italy.
- Department of Molecular Medicine and Surgery, K1 MMK Signaltransduktion, 171 77 Stockholm, Sweden.
ORCID-Profile: Nicola Rizzardi, Arianna Orsini, Chiara Diquigiovanni, Luca Pincigher, Noah Moruzzi, Romana Fato, Christian Bergamini
Förderung
- Italian Ministry of University
Zitieren
APA
Cataldi-Stagetti, E., Rizzardi, N., Orsini, A., De Nicolo, B., Diquigiovanni, C., Pincigher, L., Moruzzi, N., Fato, R., Bergamini, C., & Bonora, E. (2025). Metabolic Profiling of Distinct TP53-Mutant Esophageal Adenocarcinoma Models Reveals Different Bioenergetic Dependencies. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26146869
Vancouver
Cataldi-Stagetti E, Rizzardi N, Orsini A, De Nicolo B, Diquigiovanni C, Pincigher L, et al. Metabolic Profiling of Distinct TP53-Mutant Esophageal Adenocarcinoma Models Reveals Different Bioenergetic Dependencies. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26146869
BibTeX
@article{CataldiStagetti2025,
author = {Cataldi-Stagetti, Erica and Rizzardi, Nicola and Orsini, Arianna and De Nicolo, Bianca and Diquigiovanni, Chiara and Pincigher, Luca and Moruzzi, Noah and Fato, Romana and Bergamini, Christian and Bonora, Elena},
title = {Metabolic Profiling of Distinct TP53-Mutant Esophageal Adenocarcinoma Models Reveals Different Bioenergetic Dependencies},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26146869}
}
EUVIMED